| 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by … G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ... Journal of hypertension 41 (12), 1874-2071, 2023 | 479 | 2023 |
| Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension … R Kreutz, EAEH Algharably, M Azizi, P Dobrowolski, T Guzik, ... Cardiovascular research 116 (10), 1688-1699, 2020 | 446 | 2020 |
| Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer R Kreutz, EAH Algharably, A Douros Journal of hypertension 37 (10), 1950-1958, 2019 | 69 | 2019 |
| Authors/Task Force Members:. 2023 ESH guidelines for the management of arterial Hypertension the Task Force for the management of arterial Hypertension of the European Society … G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ... J Hypertens 41 (12), 1874-2071, 2023 | 57 | 2023 |
| Do β-blockers cause depression? Systematic review and meta-analysis of psychiatric adverse events during β-blocker therapy TG Riemer, LE Villagomez Fuentes, EAE Algharably, MS Schäfer, ... Hypertension 77 (5), 1539-1548, 2021 | 41 | 2021 |
| High prevalence of multimorbidity and polypharmacy in elderly patients with chronic pain receiving home care are associated with multiple medication-related problems J Schneider, EAE Algharably, A Budnick, A Wenzel, D Draeger, R Kreutz Frontiers in pharmacology 12, 686990, 2021 | 40 | 2021 |
| Deficits in pain medication in older adults with chronic pain receiving home care: A cross-sectional study in Germany J Schneider, E Algharably, A Budnick, A Wenzel, D Dräger, R Kreutz PLoS One 15 (2), e0229229, 2020 | 24 | 2020 |
| Improving long-term adherence to statin therapy: a qualitative study of GPs’ experiences in primary care K Krüger, N Leppkes, S Gehrke-Beck, W Herrmann, EA Algharably, ... British Journal of General Practice 68 (671), e401-e407, 2018 | 22 | 2018 |
| Small molecules as therapy for uveitis: a selected perspective of new and developing agents U Pleyer, EAH Algharably, E Feist, R Kreutz Expert Opinion on Pharmacotherapy 18 (13), 1311-1323, 2017 | 21 | 2017 |
| European Society of Hypertension COVID-19 Task Force Review. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the … R Kreutz, P Dobrowolski, A Prejbisz, EAE Algharably, G Bilo, F Creutzig, ... J Hypertens 39 (6), 1077-89, 2021 | 18 | 2021 |
| Renin-Angiotensin-System (RAS) und COVID-19 R Kreutz, EAEH Algharably, D Ganten, F Messerli Pneumologie 74 (09), 611-614, 2020 | 11 | 2020 |
| Starting antihypertensive drug treatment with combination therapy: controversies in hypertension-pro side of the argument A Persu, M Lopez-Sublet, EAEH Algharably, R Kreutz Hypertension 77 (3), 800-805, 2021 | 10 | 2021 |
| Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus–Positive Kidney Transplant Recipients E Schrezenmeier, F Hoffmann, C Jaeger, J Schrezenmeier, J Lisec, ... Therapeutic drug monitoring 41 (1), 53-58, 2019 | 10 | 2019 |
| Novel drugs in the treatment of hypertension R Kreutz, E Abdel-Hady Algharably Interventional Therapies for Secondary and Essential Hypertension, 157-178, 2016 | 3 | 2016 |
| Antihypertensive Drugs R Kreutz, EAH Algharably Encyclopedia of Molecular Pharmacology, 165-174, 2022 | 2 | 2022 |
| Blood pressure control R Kreutz, E Abd el-Hady Algharably Encyclopedia of Molecular Pharmacology, 317-322, 2022 | 2 | 2022 |
| Antihypertensive drug classes EAH Algharably, R Kreutz Manual of Hypertension of the European Society of Hypertension, Third …, 2019 | 1 | 2019 |
| Women’s health, cardiovascular risk and hypertension: the perspective still needs to improve M Burnier, J Brguljan, EAE Algharably, SE Kjeldsen, K Narkiewicz, ... Blood Pressure 32 (1), 2193648, 2023 | | 2023 |
| The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with … MG Inci, J Sehouli, E Schnura, M Lee, S Roll, T Reinhold, J Klews, ... International Journal of Gynecologic Cancer 33 (8), 2023 | | 2023 |
| New Antidiabetic Agents: Relevance to Cardiovascular Outcomes R Kreutz, EAEH Algharably Blood Pressure Disorders in Diabetes Mellitus, 337-349, 2023 | | 2023 |
